Findings show oral Mira-55 fully normalized pain and significantly reduced inflammation, supporting IND plans and reinforcing MIRA’s position in a $70 billion non-opioid pain market. MIAMI, FLORIDA / ...

The Istanbul-based healthcare group is strengthening its position in Turkiye's healthcare tourism sector by expanding ...

Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at the ...

A study published in Science Advances by University of Utah Health researchers sheds light on the long-term effects of the ...

Among 804 androgen receptor pathway inhibitor-experienced mCRPC patients, 459 patients (57.1%) received another androgen receptor pathway inhibitor as their index therapy and 192 (23.9%) received ...

Two newly approved medications expand options beyond lifestyle modifications for metabolic dysfunction-associated steatotic ...

A growing body of research suggests that how you cook your food — not just what you eat — may influence health and longevity.

Diabetes mellitus, encompassing both Type 1 (T1D) and Type 2 diabetes (T2D), threatens human health on a global scale. Diabetes affects individuals of all ...

Metabolism is rarely the culprit behind weight loss or weight gain, but there are a few ways you can boost the number of ...

Akero's lead drug candidate efruxifermin, or EFX, is currently undergoing phase-three study, and aims to be a "best-in-class" MASH treatment. This "will complement Novo Nordisk's leadership in GLP-1 ...

Biotechnology and biomanufacturing are witnessing a transformative shift with the rise of chassis cells. Serving as the cornerstone of modern ...

Doctors warn that Ozempic may interfere with PET-CT scans, potentially hiding signs of cancer and delaying diagnoses, according to new reports.